보안 및 독성
광범위한 인산디에스테라제 억제는 그 화합물에 대한 안전성과 잠재적 부작용에 대한 의문을 유발했다.임상시험과 추가 연구는 그 화합물의 안전성, 그 치료창구, 그리고 비표적효과가 임상적으로 유의미한 정도를 평가하기 위해 필요할 것이다.
화학 원료를 구입해야하는 경우 요청 정보를 제출하여최신견적을받으십시오.
보안 및 독성의 학술 논문
-
Lessons from (S)-6-(1-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3- b ]pyridazin-3-yl)ethyl)quinoline (PF-04254644), an inhibitor of receptor tyrosine kinase c-met with high protein kinase selectivity but broad phosphodiesterase family inhibition lea
화학 물질
-
6-((6-(3,4-difluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl)-methyl)quinoline
-
-
Synthesis and study of 2-amino-7-bromofluorenes modified with nitroxides and their precursors as dual anti-amyloid and antioxidant active compounds
화학 물질
-
7-bromo-N-[(1-oxyl-4-bromo-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl]-9H-fluoren-2-amine radical
-
-
Synthesis and antibacterial activity of cephalosporins having hydroxamic acid at C-7 position
화학 물질
-
C23H26N2O7
-
Glyoxylic acid
-
-
Discovery and SAR studies of 3-amino-4-(phenylsulfonyl)tetrahydrothiophene 1,1-dioxides as non-electrophilic antioxidant response element (ARE) activators
화학 물질
-
3-(phenylthio)-2,3-dihydrothiophene 1,1-dioxide
-
